These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 16406514)
1. Hypermethylation of CpG islands in p16 as a prognostic factor for diffuse large B-cell lymphoma in a high-risk group. Shiozawa E; Takimoto M; Makino R; Adachi D; Saito B; Yamochi-Onizuka T; Yamochi T; Shimozuma J; Maeda T; Kohno Y; Kawakami K; Nakamaki T; Tomoyasu S; Shiokawa A; Ota H Leuk Res; 2006 Jul; 30(7):859-67. PubMed ID: 16406514 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of O6-methylguanine DNA methyltransferase and p57 methylation in patients with diffuse large B-cell lymphomas. Lee SM; Lee EJ; Ko YH; Lee SH; Maeng L; Kim KM APMIS; 2009 Feb; 117(2):87-94. PubMed ID: 19239430 [TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of p16(INK4a) promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma. Zainuddin N; Kanduri M; Berglund M; Lindell M; Amini RM; Roos G; Sundström C; Enblad G; Rosenquist R Leuk Res; 2011 Apr; 35(4):438-43. PubMed ID: 21035853 [TBL] [Abstract][Full Text] [Related]
4. Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma. Chim CS; Wong KY; Loong F; Lam WW; Srivastava G Hum Pathol; 2007 Dec; 38(12):1849-57. PubMed ID: 17900658 [TBL] [Abstract][Full Text] [Related]
5. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer. Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319 [TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer. Kurakawa E; Shimamoto T; Utsumi K; Hirano T; Kato H; Ohyashiki K Int J Oncol; 2001 Aug; 19(2):277-81. PubMed ID: 11445839 [TBL] [Abstract][Full Text] [Related]
7. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes. Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049 [TBL] [Abstract][Full Text] [Related]
8. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression. Uccella S; Cerutti R; Placidi C; Marchet S; Carnevali I; Bernasconi B; Proserpio I; Pinotti G; Tibiletti MG; Furlan D; Capella C J Clin Pathol; 2009 Aug; 62(8):715-23. PubMed ID: 19638543 [TBL] [Abstract][Full Text] [Related]
9. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma. Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203 [TBL] [Abstract][Full Text] [Related]
10. Frequent deletion and 5' CpG island methylation of the p16 gene in primary malignant lymphoma of the brain. Zhang SJ; Endo S; Ichikawa T; Washiyama K; Kumanishi T Cancer Res; 1998 Mar; 58(6):1231-7. PubMed ID: 9515810 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic changes and their clinical relevance in Saudi diffuse large B-cell lymphoma. A molecular and tissue microarray analysis of 100 cases. Al-Kuraya KS; Siraj AK; Al-Dayel FA; Ezzat AA; Al-Jommah NA; Atizado VL; Narayanappa RN Saudi Med J; 2005 Jul; 26(7):1099-103. PubMed ID: 16047061 [TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma. Ko E; Kim Y; Kim SJ; Joh JW; Song S; Park CK; Park J; Kim DH Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2260-7. PubMed ID: 18723830 [TBL] [Abstract][Full Text] [Related]
14. Inactivation of p16 by CpG hypermethylation in renal cell carcinoma. Vidaurreta M; Maestro ML; Sanz-Casla MT; Maestro C; Rafael S; Veganzones S; Moreno J; Blanco J; Silmi A; Arroyo M Urol Oncol; 2008; 26(3):239-45. PubMed ID: 18452812 [TBL] [Abstract][Full Text] [Related]
15. Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study. Kim M; Yim SH; Cho NS; Kang SH; Ko DH; Oh B; Kim TY; Min HJ; She CJ; Kang HJ; Shin HY; Ahn HS; Yoon SS; Kim BK; Shin HR; Han KS; Cho HI; Lee DS Cancer Genet Cytogenet; 2009 Nov; 195(1):59-65. PubMed ID: 19837270 [TBL] [Abstract][Full Text] [Related]
16. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma. Nakamichi I; Tomita Y; Zhang B; Sugiyama H; Kanakura Y; Fukuhara S; Hino M; Kanamaru A; Ogawa H; Aozasa K Ann Hematol; 2007 Aug; 86(8):557-64. PubMed ID: 17508213 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis. Ota N; Kawakami K; Okuda T; Takehara A; Hiranuma C; Oyama K; Ota Y; Oda M; Watanabe G Anticancer Res; 2006; 26(5B):3729-32. PubMed ID: 17094392 [TBL] [Abstract][Full Text] [Related]
18. Methylation of p16 CpG islands associated with malignant transformation of gastric dysplasia in a population-based study. Sun Y; Deng D; You WC; Bai H; Zhang L; Zhou J; Shen L; Ma JL; Xie YQ; Li JY Clin Cancer Res; 2004 Aug; 10(15):5087-93. PubMed ID: 15297411 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias. Chim CS; Wong AS; Kwong YL Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284 [TBL] [Abstract][Full Text] [Related]
20. High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka. Takeshima M; Saitoh M; Kusano K; Nagayasu H; Kurashige Y; Malsantha M; Arakawa T; Takuma T; Chiba I; Kaku T; Shibata T; Abiko Y J Oral Pathol Med; 2008 Sep; 37(8):475-9. PubMed ID: 18284544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]